Lonza to expand inhalation capabilities at Tampa site
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
The new lab is a testament to the Pondicherry Institute of Medical Sciences (PIMS)’s long-held values and traditions of striving for excellence and embracing newer innovations in order to deliver the best standard of training for their students
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
Upon closing, the Quakertown business will become an independent company called Microsize
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
The facility is among 12 centres established worldwide, and the first in Asia
This facility will design & develop instruments, perform product reliability performance testing and verification
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Subscribe To Our Newsletter & Stay Updated